fashion -WSS

fashion

author：Wikipedia 2025-09-03 12:03:38 - browse：491

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Sanofi CEO defends move to abandon profit guidance, boost research

WSS

Chimpanzees, like humans and whales, get menopause: Study

More doctors should go into startup world

Emergency medicine has repudiated 'excited delirium.' Now what?

Emergency medicine has repudiated 'excited delirium.' Now what?

Telehealth options flood the market as retailers push virtual care

MoonLake credibility takes another hit with mid

hotspot

fashion

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

Biden's order seeks to regulate AI risk without stifling innovation

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Hospitals warn Medicare's drug payment fix is ‘unlawful’

State Dept. review finds Biden bears some blame for Afghanistan failures

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Novavax promises a turnaround & Lilly roils the obesity market

Senate panel clears PBM, hopsital reforms

Drug repurposing or repositioning? The language matters

Physician subsidies by hospitals soar in wake of No Surprises Act

knowledge

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

The new shift in health care is toward less care

Victims of gun violence feel impacts long after bullet wound

The FDA weighs the risks of candy

Extreme heat events are a public health emergency

Medicare solvency divides Republicans at the presidential debate

explore

explore

Wikipedia

hotspot